Once seen as a harmful drug, marijuana is now proving its mettle as a tool to battle deadly addictions. Read More

The economy struggles with recession, but marijuana equities are bouncing back as pot firms report brisk sales. Read More

The public is embracing the decriminalization of magic mushrooms and other psychedelics, spawning an investment theme. Read More

The U.S. House last Friday passed a COVID-19 relief bill that includes help for cannabusinesses, igniting partisan anger. Read More

Once demonized as a corrupter of youth, marijuana is winning the hearts and minds of middle America. A new poll confirms it. Read More

Marijuana laws are constantly changing and they directly affect cannabis investments. Here’s the “week in weed.” Read More

Today is the first anniversary of Denver’s decriminalization of psychedelic mushrooms. A new industry is being born. Read More

A new flurry of scientific research about pot's medical efficacy underscores the appeal of cannabis biotech investing. Read More

The virus outbreak makes it even harder to sort the gems from the dross in the cannabis sector. Here’s how to spot the best buys. Read More

As the economy contracts and unemployment worsens, small-cap cannabis companies are poised to outperform. Read More